Penumbra (PEN) FCF Margin Growth (3y) (2017 - 2026)
Penumbra (PEN) FCF Margin Growth (3y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 884.00 |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 534.00 |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | -310.00 |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 919.00 |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 3,472.00 |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | -97.00 |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 413.00 |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | -63.00 |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 60.00 |
| 10 | Penumbra | 12.76 Bn | 12.10 Bn | 264.94 Mn | 346.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 346.00 |
| Mar 31, 2026 | 1,536.00 |
| Dec 31, 2025 | 1,479.00 |
| Sep 30, 2025 | 3,319.00 |
| Jun 30, 2025 | 2,631.00 |
| Mar 31, 2025 | 1,922.00 |
| Dec 31, 2024 | 2,705.00 |
| Sep 30, 2024 | -86.00 |
| Jun 30, 2024 | 688.00 |
| Mar 31, 2024 | 2,250.00 |
| Dec 31, 2023 | 1,395.00 |
| Sep 30, 2023 | 366.00 |
| Jun 30, 2023 | 3,369.00 |
| Mar 31, 2023 | 1,639.00 |
| Dec 31, 2022 | 338.00 |
| Sep 30, 2022 | -2,717.00 |
| Jun 30, 2022 | -1,855.00 |
| Mar 31, 2022 | -237.00 |
| Dec 31, 2021 | -1,907.00 |
| Sep 30, 2021 | 513.00 |